PreveCeutical Medical Inc. PRVCF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 0.89% | -142.57% | 248.78% | 29.00% | -64.91% |
| Total Depreciation and Amortization | 0.00% | 15.38% | 0.00% | -10.34% | 31.82% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -0.91% | 109.00% | -1,775.06% | -78.60% | 177.73% |
| Change in Net Operating Assets | -0.84% | -62.13% | 2.07% | 161.32% | -80.87% |
| Cash from Operations | 0.85% | 48.00% | -1.43% | 6.74% | -457.36% |
| Capital Expenditure | -- | -- | -- | 100.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -95.45% | 13,100.00% | 100.75% |
| Cash from Investing | -- | -- | -95.45% | 2,300.00% | 95.50% |
| Total Debt Issued | 0.00% | -99.29% | -- | -- | -200.00% |
| Total Debt Repaid | -- | -- | -143.32% | 54.38% | -- |
| Issuance of Common Stock | 0.00% | -32.94% | -32.80% | -9.53% | 1,277.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -0.88% | -31.12% | -30.79% | 5.81% | 435.44% |
| Foreign Exchange rate Adjustments | 0.00% | -78.70% | 186.67% | -9,650.00% | 60.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.08% | 113.88% | -192.80% | 8,122.22% | 97.59% |